LIVN Q4 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$270M-6.3% YoY

Gross Profit

$151M56.1% margin

Operating Income

-$252M-93.4% margin

Net Income

-$284M-105.2% margin

EPS (Diluted)

$-5.76

QoQ Revenue Growth

+12.3%

Cash Flow

Operating Cash Flow

$37M

Free Cash Flow

$30M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.3B

Stockholders' Equity

$1.1B

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$270M	$288M	-6.3%
Gross Profit	$151M	$205M	-26.1%
Operating Income	-$252M	-$144M	-74.9%
Net Income	-$284M	-$143M	-98.0%

Revenue Segments

Cardiovascular Segment

$160M59%

Neuromodulation Segment

$109M41%

Geographic Segments

UNITED STATES

$138M51%

Locations Excluding The United States And Europe

$77M28%

Europe

$55M20%